Gubra is a biotech company delivering pre-clinical contract research services within obesity and diabetes. We combine cutting-edge technology, our accumulated experience and proven methodology to challenge current beliefs.

Watch our newest film to learn more about how our approach to CNS stereology can make a difference in your study.

Gubra is currently setting up an unique diet-induced NAFLD/NASH mouse model. The model includes pre-study biopsies for assessment and stratification of individual disease progression before evaluating the potential of your compound.
Contact us if you want to know more.

Gubra is hiring. See our open positions here.